Arthneeti

Choksi Laboratories Share Price & Earnings Call Analysis

₹201.75+4.78% today
Market cap
₹141 Cr
P/E
73.95
ROE
4.19%
PEG
-5.16
Price to sales
3.01
Debt to equity
1.34
52W high / low
₹219 / ₹89.7
Sales growth (5Y)
12.36%
EBITDA margin
26.72%
Net profit margin
2.24%
Promoter holding
31.48%
Sales (last year)
₹47 Cr

Potential multibaggers · Q2 FY27

Potential multibaggers in Healthcare Services
on management's own guidance

  1. Strong growth
    2
  2. Strong growth
    1
  3. Aster DM Quality Care LtdGood growth
    3
See all potential multibaggersWhere does Choksi Laborator rank?

Portfolio builder

Build your portfolio
from the top-ranked stocks

  1. 1. Pick 3–15 stocks
  2. 2. Choose large, mid or small cap and your sectors
  3. 3. Get a portfolio built from the rankings
Build my portfolio

Ranks describe management commentary on revenue and margin from the latest earnings call. Not investment advice.

Peers

Healthcare Services companies ranked on guidance

#CompanyRevenue guidedMargin guidedMarket capP/E
140%+Up 2%+₹921 Cr—
240%+Flat₹575 Cr21.9
3Aster DM Quality Care Ltd20–40%Up 2%+₹59,405 Cr164.6
420–40%Up 2%+₹551 Cr18.5
520–40%Up 0–2%₹1,635 Cr16.5
620–40%Flat₹1.21L Cr57.7

Sign up free to see every company in the sector ranking and track Choksi Laborator.

Pro shows every company guiding 40%+ revenue growth →Full Healthcare Services ranking

Choksi Laborator announcements

All announcements →

Financials of Choksi Laborator

Quarterly Results, Profit & Loss, Balance Sheet, Cash Flows, and Ratios are shown below as separate sections.

Financials of Choksi Laborator

Quarterly Results

Quarter-by-quarter operating performance

Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
Sales +9.788.887.958.7911.1210.749.2610.3811.4011.2411.1210.8212.82
Expenses +6.306.455.846.557.637.916.907.847.908.348.198.169.18
Operating Profit3.482.432.112.243.492.832.362.543.502.902.932.663.64
OPM %35.58%27.36%26.54%25.48%31.38%26.35%25.49%24.47%30.70%25.80%26.35%24.58%28.39%
Other Income +2.260.000.050.000.060.010.010.010.040.000.010.890.06
Interest0.940.820.740.670.770.720.660.690.580.600.690.810.71
Depreciation1.421.391.411.431.491.501.611.681.701.681.691.831.89
Profit before tax3.380.220.010.141.290.620.100.181.260.620.560.911.10
Tax %11.54%-59.09%0.00%57.14%46.51%30.65%20.00%44.44%26.98%38.71%57.14%64.84%6.36%
Net Profit +2.990.360.010.060.680.420.080.110.920.390.240.311.03
EPS in Rs4.290.520.010.090.980.600.110.161.320.560.340.451.48

Financials of Choksi Laborator

Profit & Loss

Annual income statement trend

Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Sales +24.4525.1028.6330.4033.7428.1625.6930.0434.4436.7041.7846.01
Expenses +19.3019.9523.8524.0626.4824.6221.5721.1424.1726.4230.4833.88
Operating Profit5.155.154.786.347.263.544.128.9010.2710.2811.3012.13
OPM %21.06%20.52%16.70%20.86%21.52%12.57%16.04%29.63%29.82%28.01%27.05%26.36%
Other Income +0.63-0.050.860.350.25-2.800.490.122.470.160.070.97
Interest1.571.231.471.591.541.892.823.233.523.062.722.82
Depreciation2.832.732.863.163.684.564.605.435.505.716.507.09
Profit before tax1.381.141.311.942.29-5.71-2.810.363.721.672.153.19
Tax %36.23%36.84%32.06%29.90%30.13%-32.05%-7.12%44.44%13.71%32.93%29.30%38.56%
Net Profit +0.880.720.891.351.60-3.88-2.610.213.211.111.521.96
EPS in Rs1.261.031.281.942.30-5.57-3.750.304.611.592.182.81
Dividend Payout %0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%

Financials of Choksi Laborator

Balance Sheet

Capital structure and asset base

Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital6.976.976.976.976.976.976.976.976.976.976.976.97
Reserves12.3513.0714.1615.4317.0413.2610.7810.9414.1415.2516.6418.61
Borrowings +11.6513.6811.2012.4317.0531.6439.1537.2932.4130.8729.1530.82
Other Liabilities +6.708.818.329.8514.2813.149.489.226.848.8612.5715.52
Total Liabilities37.6742.5340.6544.6855.3465.0166.3864.4260.3661.9565.3371.92
Fixed Assets +19.2817.6422.2328.6234.8133.0850.3246.5644.8343.4347.6151.55
CWIP2.738.994.280.003.2313.060.501.670.312.990.000.40
Investments0.000.000.000.000.000.000.000.000.000.000.000.00
Other Assets +15.6615.9014.1416.0617.3018.8715.5616.1915.2215.5317.7219.97
Total Assets37.6742.5340.6544.6855.3465.0166.3864.4260.3661.9565.3371.92

Financials of Choksi Laborator

Cash Flows

Operating, investing and financing cash movement

Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Cash from Operating Activity +2.300.016.576.256.912.875.907.888.2511.5511.787.86
Cash from Investing Activity +-0.73-0.01-1.88-4.92-9.76-13.76-7.65-2.71-0.71-6.65-7.61-7.07
Cash from Financing Activity +-1.370.00-4.89-0.942.1311.091.63-5.07-7.61-4.58-4.22-1.20
Net Cash Flow0.210.00-0.200.39-0.720.20-0.120.10-0.070.32-0.04-0.41
Free Cash Flow1.400.004.181.30-3.09-11.18-2.185.057.344.544.090.62
CFO/OP53%0%124%124%137%111%68%75%73%117%122%69%

Financials of Choksi Laborator

Ratios

Working capital efficiency and return ratios

Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days126.15124.77112.19118.6295.0990.60115.94125.03112.87103.3398.46116.85
Inventory Days0.000.0028.2730.5037.8920.2815.6246.0934.6851.3365.9425.47
Days Payable591.13594.31660.70723.24685.97741.06297.29560.33639.34594.19
Cash Conversion Cycle126.15124.77-450.67-445.18-527.72-612.36-554.41-569.95-149.73-405.67-474.95-451.87
Working Capital Days29.263.34-23.71-18.3728.0221.13-49.73-23.3311.66-49.13-71.29-35.14
ROCE %7.94%7.51%7.33%10.51%10.09%-1.48%0.00%6.40%9.16%8.87%9.20%9.64%

Continue your research

Others in Healthcare Services this season

  • Vijaya Diagnostic Centre (Q2 FY27)

    Q2 FY27 Revenue from Operations: INR 2,554 Mn, up 26.7% YoY (Page 10, 9) . Key investor presentation takeaways from Vijaya Diagnostic Centre Ltd's Q2 FY27 inves

  • Shalby (Q2 FY27)

    Consolidated Total Revenue for Q2 FY27: ₹3,182 million vs ₹2,899 million in Q2 FY26, up 9.8% YoY (Pages 5, 6, 8, 9) . Key investor presentation takeaways from S

  • Metropolis Healt (Q2 FY27)

    Q2FY27 revenue from operations: INR 496.8 Cr, up 15.8% YoY (Page 11) . Key investor presentation takeaways from Metropolis Healthcare Ltd's Q2 FY27 investor pre

  • Nephrocare Health Services (Q2 FY27)

    Q2 FY27 Revenue from Operations: ₹303.4 Cr, up 23.5% YoY from ₹245.7 Cr in Q2 FY26 (Page 9). Key investor presentation takeaways from Nephrocare Health Services

Compare:vs Apollo Hospitalsvs Max Healthcarevs Manipal Health